Cysmethynil binds ICMT:Zn2+

Stable Identifier
R-HSA-9656775
Type
Reaction [binding]
Species
Homo sapiens
Compartment
endoplasmic reticulum membrane, cytosol
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Cysmethynil binds ICMT:Zn2+
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Cysmethnil is a small molecule inhibitor of ICMT that has been shown to reduce proliferation of cancer cell lines by promoting apoptosis (Winter-Vann et al, 2005; Wang et al, 2010; Judd et al, 2011; Sun et al, 2016; Manu et al, 2017). Cysmethynil is a poor candidate for clinical trials due to low solubility and other physical characteristics. A number of related small molecule inhibitors with improved physical properties are under investigation (Lau et al, 2014; Ramanujulu et al, 2013).
Literature References
PubMed ID Title Journal Year
26706195 Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukemia

Chuah, C, Bunte, RM, Asari, K, Casey, PJ, Sun, WT, Xiang, W, Wang, M, Ng, BL

Exp. Hematol. 2016
12750467 Targeting Ras signaling through inhibition of carboxyl methylation: an unexpected property of methotrexate

Kamen, BA, Casey, PJ, Bergo, MO, Melnyk, S, Young, SG, Winter-Vann, AM, James, SJ

Proc. Natl. Acad. Sci. U.S.A. 2003
24971579 An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo

Guo, D, Yang, T, Wirawan, M, Casey, PJ, Lau, HY, Wang, M, Go, ML, Ramanujulu, PM

Cancer Biol. Ther. 2014
21661760 Discovery and SAR of methylated tetrahydropyranyl derivatives as inhibitors of isoprenylcysteine carboxyl methyltransferase (ICMT)

Hoang, KC, Roth, B, Valppu, L, Brown, B, Judd, WR, Wettstein, D, Richards, B, Willardsen, JA, Bhoite, L, Alberts, G, Ostanin, K, Huang, L, Slattum, PM

J. Med. Chem. 2011
20622895 Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth

Casey, PJ, Wang, M, Liu, S, Coolman, B, Zhou, J, Hossain, MS, Tan, W

Oncogene 2010
28167504 Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer

Casey, PJ, Zhu, WL, Wang, M, Manu, KA, Chai, TF, Teh, JT

Mol. Cancer Ther. 2017
23514631 Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt)

Wong, FC, Yang, T, Yap, SQ, Casey, PJ, Wang, M, Go, ML, Ramanujulu, PM

Eur J Med Chem 2013
Participants
Input
Output
Participates
as an event of
Disease
Name Identifier Synonyms
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Authored
Rothfels, K  (2019-10-25)
Reviewed
Gavathiotis, E  (2020-05-04)
Created
Rothfels, K  (2019-08-02)
Cite Us!